The vaccine made by Pfizer and its partner BioNTech now carries the strongest endorsement from the Food and Drug Administration, which has never before had so much evidence to judge a shot’s safety.
The U.S. gave full approval to Pfizer’s COVID-19 vaccine Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet.
The U.S. becomes the first country to fully approve the shot, according to Pfizer, and CEO Albert Bourla said in a statement he hoped the decision “will help increase confidence in our vaccine, as vaccination remains the best tool we have to help protect lives.”U.S. vaccinations bottomed out in July. As the Delta variant fills hospital beds, shots are on the rise again — with a million a day given Thursday, Friday and Saturday. Just over half of the U.S.
“Mandating becomes much easier when you have full approval,” said Dr. Carlos del Rio of Emory University. “I think a lot of businesses have been waiting for it.” Even after hundreds of millions of shots, serious side effects — such as chest pain and heart inflammation in teens and young adults — remain exceedingly rare, the FDA said.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer Booster Significantly Lowers Risk Of Covid-19 Infection Among Elderly, Israeli Gov’t FindsA third shot of the Pfizer vaccine dramatically reduced the risk of Covid-19 infection and subsequent hospitalization among people who are older than 60.
Weiterlesen »
Pfizer Booster Significantly Lowers Risk Of Covid-19 Infection Among Elderly, Israeli Data ShowsPfizer Booster Significantly Lowers Risk Of Covid-19 Infection Among Elderly, Israeli Gov’t Finds
Weiterlesen »
FDA grants full approval to Pfizer COVID-19 vaccineBREAKING: FDA grants full approval of the Pfizer COVID-19 vaccine, becoming the first COVID-19 vaccine to transition from an emergency authorization status to full FDA approval.
Weiterlesen »
US regulators give full approval to Pfizer COVID-19 vaccineWASHINGTON (AP) — The U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious coronavirus mutant yet.
Weiterlesen »
FDA grants full approval to Pfizer/BioNTech Covid-19 vaccine, opening door to more vaccine mandatesThe US Food and Drug Administration on Monday granted full approval to the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older. This is the first coronavirus vaccine approved by the FDA, and is expected to open the door to more vaccine mandates.
Weiterlesen »
FDA could grant full approval to Pfizer/BioNTech Covid-19 vaccine today, two officials sayCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
Weiterlesen »